Floatz logo

TEMUTERKIB

Stage IVA Colon Cancer AJCC v8

M.D. Anderson Cancer CenterSmall moleculePhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

18 Active assets in the Stage IVA Colon Cancer AJCC v8 cohort.

Asset / SponsorPhaseRating
Tranexamic Acid
Assaf-Harofeh Medical Center
Phase 4BB
Eloxatin
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2BB
FLUOROURACILUM
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase 2BB
Cetuximab
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase 2B
Regorafenib
City of Hope Medical Center
Phase 2B

View all 34 →

Same molecule, other indications

TEMUTERKIB is also rated in:

cancerDormant
CCC
Indicative ·
55 / 100
View asset →
pancreatic neoplasmDormant
CCC
Indicative ·
50 / 100
View asset →
colorectal carcinomaDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →